| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 29.15B | 28.68B | 27.60B | 25.80B | 22.57B | 14.46B |
| Gross Profit | 14.34B | 14.16B | 13.35B | 12.48B | 11.97B | 7.09B |
| EBITDA | 6.22B | 6.12B | 6.31B | 6.97B | 6.53B | 3.31B |
| Net Income | 2.80B | 3.01B | 3.19B | 4.06B | 4.01B | 1.70B |
Balance Sheet | ||||||
| Total Assets | 36.78B | 35.71B | 34.21B | 33.65B | 30.27B | 14.59B |
| Cash, Cash Equivalents and Short-Term Investments | 17.05B | 15.76B | 8.94B | 8.03B | 15.15B | 7.19B |
| Total Debt | 1.78B | 1.94B | 2.54B | 2.14B | 1.32B | 1.05B |
| Total Liabilities | 9.61B | 9.60B | 9.80B | 9.31B | 9.17B | 5.90B |
| Stockholders Equity | 27.17B | 26.10B | 24.41B | 24.33B | 21.10B | 8.69B |
Cash Flow | ||||||
| Free Cash Flow | 3.52B | 3.76B | 2.87B | 2.08B | 5.50B | 2.02B |
| Operating Cash Flow | 4.95B | 5.27B | 4.69B | 3.91B | 6.53B | 2.76B |
| Investing Cash Flow | 3.14B | -839.62M | -2.45B | -9.48B | -6.54B | -991.55M |
| Financing Cash Flow | -2.33B | -2.32B | -4.22B | -1.89B | 7.60B | -513.49M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | HK$56.09B | 15.11 | 10.64% | 3.83% | 4.12% | -7.17% | |
69 Neutral | HK$4.76B | 8.02 | 19.99% | 7.41% | 11.18% | -1.06% | |
68 Neutral | HK$223.60B | 15.20 | 21.07% | 3.10% | 13.55% | 13.30% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
50 Neutral | HK$325.17M | -7.10 | -37.46% | 4.17% | -13.08% | -21.27% | |
41 Neutral | HK$115.46M | -5.42 | -26.02% | ― | 157.17% | 39.38% | |
41 Neutral | HK$397.89M | -18.05 | -10.23% | ― | -5.36% | -63.16% |